Challenges and clinical relevance of molecular detection of Bordetella pertussis in South Africa
- PMID: 30898099
- PMCID: PMC6429695
- DOI: 10.1186/s12879-019-3869-7
Challenges and clinical relevance of molecular detection of Bordetella pertussis in South Africa
Abstract
Background: We assessed the utility of a multi-target, real-time PCR assay for Bordetella pertussis detection and diagnosis in patients with severe respiratory illness (SRI), influenza-like illness (ILI), and asymptomatic controls.
Methods: Real-time PCR detection of IS481, pIS1001, hIS1001 and ptxS1 was performed on nasopharyngeal specimens (SRI, ILI and controls) and induced sputum (SRI) collected from June 2012 to May 2016 through respiratory illness surveillance. Using PCR cycle threshold (Ct) value cut-offs, IS481 positive cases were classified as confirmed (Ct < 35) or possible (Ct 35-39) pertussis disease.
Results: Among 12,922 samples, 146 (1.1%) were IS481 positive of which 62% (90/146) were classified as confirmed. The attributable fraction (AF) was 92.2% (95% CI, 65.6 to 98.2%) and 90.5% (95% CI, 57.5 to 97.9%) amongst SRI and ILI PCR-confirmed pertussis cases, respectively. Amongst possible pertussis cases, AF was 36.9% (95% CI, - 142.3 to 83.6%) and 67.5% (95% CI, - 30.6 to 91.9%) in the SRI and ILI groups, respectively.
Conclusion: All IS481 positive specimens could be considered as B. pertussis infection, and potentially pertussis disease with supportive clinical information.
Keywords: Attributable fraction; Bordetella pertussis; Confirmed-pertussis; Influenza-like illness (ILI); Possible-pertussis; Real-time PCR; Severe respiratory illness; South Africa; Surveillance.
Conflict of interest statement
Ethics approval and consent to participate
Ethics for SRI (M081042) and ILI (M120133) surveillance and
Consent for publication
Not applicable.
Competing interests
Halima Dawood has received honoraria/travel grants from Pfizer-South Africa, MSD329 South Africa and Mylan-South Africa. Anne von Gottberg has previously received grants from the US Centers for Disease Control and Prevention and Pfizer-South Africa. All other authors declare that they have no commercial or other association that may pose a conflict of interest.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures


Similar articles
-
Comparison of Bordetella species identification among differing rt-PCR assays in the United States.Microbiol Spectr. 2024 Aug 6;12(8):e0078324. doi: 10.1128/spectrum.00783-24. Epub 2024 Jul 9. Microbiol Spectr. 2024. PMID: 38980022 Free PMC article.
-
[Detection of Bordetella pertussis infection by culture, real-time polymerase chain reaction and serologic tests among children with prolonged cough].Mikrobiyol Bul. 2012 Apr;46(2):211-24. Mikrobiyol Bul. 2012. PMID: 22639310 Turkish.
-
Incidence and Diagnosis of Pertussis in South African Children Hospitalized With Lower Respiratory Tract Infection.Pediatr Infect Dis J. 2016 Jun;35(6):611-6. doi: 10.1097/INF.0000000000001132. Pediatr Infect Dis J. 2016. PMID: 26967813
-
Comparing the Yield of Nasopharyngeal Swabs, Nasal Aspirates, and Induced Sputum for Detection of Bordetella pertussis in Hospitalized Infants.Clin Infect Dis. 2016 Dec 1;63(suppl 4):S181-S186. doi: 10.1093/cid/ciw521. Clin Infect Dis. 2016. PMID: 27838671 Free PMC article.
-
Pertussis: relevant species and diagnostic update.Clin Lab Med. 2014 Jun;34(2):237-55. doi: 10.1016/j.cll.2014.02.003. Epub 2014 Apr 12. Clin Lab Med. 2014. PMID: 24856526 Review.
Cited by
-
Incidence and Transmission Dynamics of Bordetella pertussis Infection in Rural and Urban Communities, South Africa, 2016‒2018.Emerg Infect Dis. 2023 Feb;29(2):294-303. doi: 10.3201/eid2902.221125. Emerg Infect Dis. 2023. PMID: 36692337 Free PMC article.
-
[Pertussis worldwide. Vaccinating children and adults].Med Trop Sante Int. 2023 Nov 22;3(4):mtsi.v3i4.2023.446. doi: 10.48327/mtsi.v3i4.2023.446. eCollection 2023 Dec 31. Med Trop Sante Int. 2023. PMID: 38390013 Free PMC article. French.
-
Vaccine-Induced Cellular Immunity against Bordetella pertussis: Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines.Vaccines (Basel). 2021 Aug 7;9(8):877. doi: 10.3390/vaccines9080877. Vaccines (Basel). 2021. PMID: 34452002 Free PMC article. Review.
-
Young Zambian infants with symptomatic RSV and pertussis infections are frequently prescribed inappropriate antibiotics: a retrospective analysis.PeerJ. 2023 May 11;11:e15175. doi: 10.7717/peerj.15175. eCollection 2023. PeerJ. 2023. PMID: 37193027 Free PMC article.
-
Genomic characterization of Bordetella pertussis in South Africa, 2015-2019.Microb Genom. 2023 Dec;9(12):001162. doi: 10.1099/mgen.0.001162. Microb Genom. 2023. PMID: 38117675 Free PMC article.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical